MarkDEisnerMD

PubMed

• 3 citations
  Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease.
  Pascal Chanu, Franz Schaefer, Bradley A. Warady, Claus Peter Schmitt, Bruno Reigner, Gabriel Schnetzler, Sylvie Meyer Reigner, Mark D. Eisner, Arlette Weichert, Nicola...> ;British Journal of Clinical Pharmacology. 2020 Jan 21
• 41 citations
  Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement
  Brett Ley, Thomas H. Urbania, Gail Husson, Eric Vittinghoff, David R Brush, Mark D. Eisner, Carlos Iribarren, Harold R. Collard> ;Annals of the American Thoracic Society. 2017 Jun 1
• 14 citations
  Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controll...
  Carlos Iribarren, Kenneth J. Rothman, Mary S. Bradley, Gillis Carrigan, Mark D. Eisner, Hubert Chen> ;The Journal of Allergy and Clinical Immunology. 2017 May 1
• 56 citations
  Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma
  Carlos Iribarren, Abdelkader Rahmaoui, Aidan A. Long, Stanley J. Szefler, Mary S. Bradley, Gillis Carrigan, Mark D. Eisner, Hubert Chen, Theodore A. Omachi, Michael E....> ;The Journal of Allergy and Clinical Immunology. 2017 May 1
• 311 citations
  Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled t...
  Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman, Eric D. Bateman, Petr Kopecky, Pierluigi Paggiaro, Akihito Yokoyama, Julie Olsson, Sarah Gray, Cecile T.J....> ;The Lancet. Respiratory Medicine. 2016 Oct 1
• 9 citations
  Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort
  Nirupama Putcha, R. Graham Barr, MeiLan K. Han, Prescott G. Woodruff, Eugene R. Bleecker, Richard E. Kanner, Fernando J. Martinez, Benjamin M. Smith, Donald P. Tashkin...> ;Thorax. 2016 Mar 9
• 64 citations
  Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.
  Laura M. Paulin, Gregory B. Diette, Paul D. Blanc, Nirupama Putcha, Mark D. Eisner, Richard E. Kanner, Andrew J. Belli, Stephanie A. Christenson, Donald P. Tashkin, Me...> ;American Journal of Respiratory and Critical Care Medicine. 2015 Feb 27
• 84 citations
  Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome
  Colin K. Grissom, Eliotte L. Hirshberg, Justin Dickerson, Samuel M. Brown, Michael J. Lanspa, Kathleen D. Liu, David A. Schoenfeld, Mark Tidswell, R. Duncan Hite, Pete...> ;Critical Care Medicine. 2015 Feb 1
• 146 citations
  Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
  Aidan A. Long, Abdelkader Rahmaoui, Kenneth J. Rothman, Eva C. Guinan, Mark D. Eisner, Mary S. Bradley, Carlos Iribarren, Hubert Chen, Gillis Carrigan, Karin Rosén, St...> ;The Journal of Allergy and Clinical Immunology. 2014 Sep 1
• 9 citations
  Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?
  Theodore A. Omachi, Steven E. Gregorich, Mark D. Eisner, Renee A. Penaloza, Irina Tolstykh, Edward H. Yelin, Carlos Iribarren, R. Adams Dudley, Paul D. Blanc> ;Medical Care. 2013 Aug 1
• 8 citations
  Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy.
  Rui Zhu, Yanan Zheng, Wendy S. Putnam, Jennifer Visich, Mark D. Eisner, John G. Matthews, Karin Rosén, David Z. D'Argenio> ;The AAPS Journal. 2013 Feb 15
• 17 citations
  Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab.
  Hubert Chen, Mark D. Eisner, Tmirah Haselkorn, Benjamin Trzaskoma> ;Respiratory Medicine. 2013 Jan 1
• 144 citations
  Adult Asthma and Risk of Coronary Heart Disease, Cerebrovascular Disease, and Heart Failure: A Prospective Study of 2 Matched Cohorts
  Carlos Iribarren, Irina Tolstykh, Mary K. Miller, Erica Sobel, Mark D. Eisner> ;American Journal of Epidemiology. 2012 Dec 1
• 24 citations
  Longitudinal Changes in Asthma Control with Omalizumab: 2-Year Interim Data from the EXCELS Study
  Mark D. Eisner, James L. Zazzali, Mary K. Miller, Mary S. Bradley, Michael Schatz> ;The Journal of Asthma. 2012 Jul 16
• 34 citations
  Trends in the incidence of noncardiogenic acute respiratory failure: the role of race
  Colin R. Cooke, Sara E. Erickson, Mark D. Eisner, Greg S. Martin> ;Critical Care Medicine. 2012 May 1
• 111 citations
  Omalizumab and the risk of malignancy: Results from a pooled analysis
  William W. Busse, Roland Buhl, Carlos Fernandez Vidaurre, M. Blogg, Jin Zhu, Mark D. Eisner, Janice Canvin> ;The Journal of Allergy and Clinical Immunology. 2012 Apr 1
• 24 citations
  Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD.
  Moshe Zutler, Jonathan P. Singer, Theodore A. Omachi, Mark D. Eisner, Carlos Iribarren, Patricia P. Katz, Paul D. Blanc> ;Primary Care Respiratory Journal. 2012 Mar 28
• 45 citations
  Severity of Asthma Score Predicts Clinical Outcomes in Patients With Moderate to Severe Persistent Asthma
  Mark D. Eisner, Ashley Yegin, Benjamin Trzaskoma> ;Chest. 2012 Jan 1
• 1166 citations
  Lebrikizumab Treatment in Adults with Asthma
  Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania, Phillip E. Korenblat, Merdad V. Parsey, Joseph R. Arron, Jeffrey M. Harris, Heleen Scheerens, Lawren C. Wu, Zhe...> ;The New England Journal of Medicine. 2011 Sep 21
• Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.
  Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, Holets S, Kallet RH, Liu KD, MacIntyre N, Moss M, Schoenfeld D, Steingrub J, Thompson BT> ;Am. J. Respir. Crit. Care Med.. 2011-09-01
• 110 citations
  Active and Passive Cigarette Smoking and Acute Lung Injury after Severe Blunt Trauma
  Carolyn S. Calfee, Michael A. Matthay, Mark D. Eisner, Neal L. Benowitz, Mariah Call, Jean-Francois Pittet, Mitchell J. Cohen> ;American Journal of Respiratory and Critical Care Medicine. 2011 Jun 15
• 398 citations
  Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.
  Nicola A. Hanania, Oral Alpan, Daniel L. Hamilos, John J. Condemi, Irmarie Reyes-Rivera, Jin Zhu, Karin Rosén, Mark D. Eisner, Dennis A. Wong, William W. Busse> ;Annals of Internal Medicine. 2011 May 3
• 14 citations
  Decreased respiratory system compliance on the sixth day of mechanical ventilation is a predictor of death in patients with established acute lung injury
  Eric J. Seeley, Daniel F. McAuley, Mark D. Eisner, Michael Miletin, Hanjing Zhuo, Michael A. Matthay, Richard H Kallet> ;Respiratory Research. 2011 Apr 22
• 93 citations
  Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.
  Carolyn S. Calfee, Lorraine B. Ware, David V. Glidden, Mark D. Eisner, Polly E. Parsons, B. Taylor Thompson, Michael A. Matthay> ;Critical Care Medicine. 2011 Apr 1
• 34 citations
  Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency
  Theodore A. Omachi, Mark D. Eisner, Alexis Rames, Lada Markovtsova, Paul D. Blanc> ;Respiratory Research. 2011 Mar 23
• Join now to see all